HONG KONG, Jun 24, 2026 – (ACN Newswire) – Everest Medicines (HKEX 1952.HK) announced that Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui’s budesonide enteric capsules, which were approved by the National Medical Products Administration (NMPA) in December 2025.Pursuant to this collaboration…
Read More
